Frankfurt - Delayed Quote EUR
Lipigon Pharmaceuticals AB (publ) (9RP.F)
0.0038
0.0000
(0.00%)
At close: May 23 at 8:11:36 AM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
14,823
33,602
10,816
29,428
Total Liabilities Net Minority Interest
7,062
5,158
6,945
6,466
Total Equity Gross Minority Interest
7,761
28,444
3,871
22,962
Total Capitalization
7,761
28,444
3,871
22,962
Common Stock Equity
7,761
28,444
3,871
22,962
Net Tangible Assets
7,761
28,444
3,871
22,962
Working Capital
7,536
28,395
3,799
22,866
Invested Capital
7,761
28,444
3,871
22,962
Tangible Book Value
7,761
28,444
3,871
22,962
Share Issued
193,274.4710
164,728.0670
31,931.8170
17,270.8180
Ordinary Shares Number
193,274.4710
164,728.0670
31,931.8170
17,270.8180
Treasury Shares Number
--
0
--
--
12/31/2021 - 3/3/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DIABIO.ST Diagonal Bio AB (publ)
0.0145
0.00%
9F1.F Diagonal Bio AB (publ)
0.0002
0.00%
NANECH.ST NanoEcho AB
0.1034
+0.39%
ISOFOL.ST Isofol Medical AB (publ)
1.1470
-4.34%
ACTI.ST Active Biotech AB (publ)
0.2410
+53.90%
ONCO.ST Oncopeptides AB (publ)
1.9960
+1.32%
STTK Shattuck Labs, Inc.
1.0800
+8.00%
SGMT Sagimet Biosciences Inc.
3.4500
+1.17%
ETNB 89bio, Inc.
9.49
-1.66%
MDGL Madrigal Pharmaceuticals, Inc.
267.56
-2.12%